Sean Wieland
Stock Analyst at Piper Sandler
(1.88)
# 3,251
Out of 5,122 analysts
31
Total ratings
45.45%
Success rate
3.12%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $46.69 | +17.80% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $22.01 | +63.60% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $4.40 | +2,627.27% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $24.40 | -75.41% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $35.25 | +24.82% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $202.54 | +14.05% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $4.91 | +5,826.68% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $46.69
Upside: +17.80%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $22.01
Upside: +63.60%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $4.40
Upside: +2,627.27%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $24.40
Upside: -75.41%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $35.25
Upside: +24.82%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $202.54
Upside: +14.05%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $4.91
Upside: +5,826.68%